XML 16 R4.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenue:        
Net product sales $ 44,130 $ 21,309 $ 78,176 $ 38,005
Cost of goods sold 5,367 3,135 9,422 5,750
Gross profit 38,763 18,174 68,754 32,255
Operating expenses:        
Research and development 70,981 34,660 135,574 75,458
Selling, general and administrative 42,578 29,172 86,881 56,568
Changes in fair value of contingent consideration payable 480 300 1,863 1,400
Depreciation and amortization 1,154 973 2,145 1,942
Total operating expenses 115,193 65,105 226,463 135,368
Loss from operations (76,430) (46,931) (157,709) (103,113)
Other income (expense):        
Interest income 2,599 2,913 5,238 4,650
Interest expense (4,625) (4,560) (11,079) (9,048)
Loss on exchange of convertible notes (4,501) 0 (40,624) 0
Change in fair value of derivatives 0 (7,600) 0 (2,739)
Other (expense) income (877) (5,316) 209 (2,554)
Loss before income tax (83,834) (61,494) (203,965) (112,804)
Income tax benefit (717) (339) (885) 1,053
Net loss attributable to common stockholders $ (84,551) $ (61,833) $ (204,850) $ (111,751)
Net loss attributable to common stockholders per common share - basic and diluted (in dollars per share) $ (0.36) $ (0.33) $ (0.91) $ (0.61)
Weighted-average common shares outstanding - basic and diluted (in shares) 238,089,824 188,621,423 225,848,013 182,303,128